Intranasal drug delivery is one of the most preferred drug delivery routes among patients as well as healthcare providers.
This can be majorly attributed to the non-invasive nature of this route of delivery and the fact that drug absorbability is higher through the nasal route.The global nasal drug delivery technology market is projected to reach USD 64.20 billion by 2021 from USD 44.00 billion in 2016, at a CAGR of 6.5% during the forecast period.Increasing patient preference for nasal drug delivery as a result of easy administration and better efficacyIntranasal drug delivery is one of the most preferred drug delivery routes among patients as well as healthcare providers.
This can majorly be attributed to the non-invasive nature of this route of delivery and the fact that drug absorbability is higher through the nasal route.
In addition, the nasal route offers a less hostile environment as compared to the gastro-intestinal route; this enables better absorption of drugs.
Moreover, nasal drug delivery, unlike some other routes of drug delivery, dose not require any sterile method for administering drugs into the body.
Considering these factors, the preference for nasal drug delivery is increasing among patients as well as healthcare providers.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=192818058Furthermore, growth among over-the-counter nasal drugs and increasing focus on alternative routes of drug delivery such as nasal drug delivery offer significant growth opportunities for player operating in the market.